Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Sales | 97,630 | 88,450 | 80,243 | 72,234 | 85,393 |
| Cost of Goods | 85,140 | 70,281 | 64,782 | 58,854 | 71,220 |
| Gross Profit | 20,870 | 18,169 | 15,461 | 13,380 | 18,160 |
| Operating Expenses | 9,160 | 8,192 | 8,901 | 8,347 | 8,780 |
| Operating Income | 3,470 | 10,258 | 7,342 | 5,887 | 5,613 |
| Interest Expense | 2,240 | 2,095 | 2,011 | 2,050 | 2,170 |
| Other Income | 8,510 | 0 | 0 | 0 | -1,163 |
| Pre-tax Income | 9,740 | 8,163 | 5,331 | 3,837 | 2,280 |
| Income Tax | 2,930 | 2,382 | 1,534 | 1,151 | 750 |
| Net Income Continuous | 7,185 | 5,781 | 3,797 | 2,686 | 2,615 |
| Net Income | $7,185 | $5,781 | $3,797 | $2,686 | $2,615 |
| EPS Basic Total Ops | 0.11 | 0.09 | 0.06 | 0.05 | 0.04 |
| EPS Basic Continuous Ops | 0.11 | 0.09 | 0.06 | 0.04 | 0.04 |
| EPS Diluted Total Ops | 0.11 | 0.09 | 0.06 | 0.04 | 0.04 |
| EPS Diluted Continuous Ops | 0.11 | 0.09 | 0.06 | 0.04 | 0.04 |
| EBITDA(a) | $8,400 | $15,157 | $11,964 | $10,646 | $9,973 |